Jump to navigation Jump to search
Clinical data
ATC code
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass304.467 g/mol

WikiDoc Resources for Mesterolone


Most recent articles on Mesterolone

Most cited articles on Mesterolone

Review articles on Mesterolone

Articles on Mesterolone in N Eng J Med, Lancet, BMJ


Powerpoint slides on Mesterolone

Images of Mesterolone

Photos of Mesterolone

Podcasts & MP3s on Mesterolone

Videos on Mesterolone

Evidence Based Medicine

Cochrane Collaboration on Mesterolone

Bandolier on Mesterolone

TRIP on Mesterolone

Clinical Trials

Ongoing Trials on Mesterolone at Clinical

Trial results on Mesterolone

Clinical Trials on Mesterolone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mesterolone

NICE Guidance on Mesterolone


FDA on Mesterolone

CDC on Mesterolone


Books on Mesterolone


Mesterolone in the news

Be alerted to news on Mesterolone

News trends on Mesterolone


Blogs on Mesterolone


Definitions of Mesterolone

Patient Resources / Community

Patient resources on Mesterolone

Discussion groups on Mesterolone

Patient Handouts on Mesterolone

Directions to Hospitals Treating Mesterolone

Risk calculators and risk factors for Mesterolone

Healthcare Provider Resources

Symptoms of Mesterolone

Causes & Risk Factors for Mesterolone

Diagnostic studies for Mesterolone

Treatment of Mesterolone

Continuing Medical Education (CME)

CME Programs on Mesterolone


Mesterolone en Espanol

Mesterolone en Francais


Mesterolone in the Marketplace

Patents on Mesterolone

Experimental / Informatics

List of terms related to Mesterolone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Mesterolone is an orally applicable androgen, and DHT derivative. It is sold under the brand name Proviron, by Schering. In the late 70's and early 80's it was used with some success in controlled studies of men suffering from various forms of depression.

In one randomized, double-blind 4-week trial, 38 dysthymic men were administered 75mg daily. Itil & Colleagues reported an improvement of symptoms which included anxiety, lack of drive and desire. Next, they administered a high dose (450mg/day) or placebo in a 6-week randomized trial of 52 men with a mean age of 40 years, suffering from dysthymia, unipolar and bipolar depression. Both the mesterolone and placebo groups improved significantly and there were no statistically significant differences between the two groups. In this series of studies mesterolone lead to a significant decrease in LH and testosterone levels. This is probably as a result of the extremely high dose used. In another, 100mg mesterolone cipionate was administered twice monthly. With regards to plasma T levels, there was no difference between the treated vs untreated group, and baseline LH levels were minimally affected.[1]

Mesterolone is a relatively weak androgen and rarely used for replacement therapies.[2]


Template:Anabolic steroids

Template:WikiDoc Sources